Lipella Pharmaceuticals Inc. Retained Earnings
Lipella Pharmaceuticals Inc. (LIPO) had Retained Earnings of -$19.23 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-14
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$19.23M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$17.97M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$16.65M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$15.34M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$19.23M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$17.97M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$16.65M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$15.34M 10-Q · filed 2025-11-14 |
| 2024-09-30 | -$13.90M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$12.45M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$11.52M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$10.32M 10-K · filed 2025-03-28 |
| 2023-09-30 | -$9.63M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$8.31M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$6.77M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$5.70M 10-K · filed 2024-02-27 |
| 2021-12-31 | -$3.11M 10-K · filed 2023-03-31 |